Case Study | A Novel Approach for Accelerated Development of CAR-T Manufacturing Process for Autologous Cell Therapies

Cellipont has partnered with Adva Biotechnology to revolutionize autologous CAR-T cell therapy manufacturing using ADVA’s innovative CAMP® technology and ADVA-X3 system. This collaboration aims to streamline production, enhance therapy quality, and improve accessibility by addressing key challenges in scalability, efficiency, and cost-effectiveness of cell therapy manufacturing processes.